Sanford Limited (SARDY) Fair Value & Analysis
Consumer Defensive · US · Market cap $351M
Fair value as of: Jun 24, 2026
Analysis
Sanford Limited (SARDY) currently trades at $19.40, while our model-based Fair Value estimate is $28.33 — implying the stock looks roughly 46.0% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Sanford Limited engages in the farming, harvesting, processing, storage, and marketing of seafood products. It operates through Wildcatch and Aquaculture segments. The company catches and processes inshore and deepwater fish species, as well as farms, harvests, and processes mussels and salmon. Its products include Antarctic toothfish, arrow squid, gemfish, greenshell mussels, hake, hapuku, hoki, king salmon, ling, monkfish, New Zealand sole, orange roughy, scampi, silver warehou, smooth oreo dory, southern blue whiting, and yellowbelly flounder. The company operates in North America, China, New Zealand, Europe, Australia, Other Asian countries, Japan, South Korea, the Middle East, Hong Kong, Central and South America, Africa, and the Pacific. Sanford Limited was founded in 1881 and is headquartered in Auckland, New Zealand.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Sanford Limited (SARDY) undervalued?
What is the fair value of SARDY?
What is the quality score of SARDY?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.